Mechanistic study of Small-molecular Therapy in diabetic Wound Healing

小分子治疗糖尿病伤口愈合的机制研究

基本信息

  • 批准号:
    10366031
  • 负责人:
  • 金额:
    $ 37.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Diabetic foot ulcers that lead to amputations are a major health problem affecting ~20% of the 30 million diabetic patients in the US. The current regimen has limited success, and the amputation rates remain high. Therefore, understanding molecular mechanisms for compounds with translational potential is a crucial step toward making a breakthrough in wound care protocols. Endothelial cells (ECs) are indispensable cellular components for wound angiogenesis. However, EC functions are impaired in patients with diabetes. The coformulation of two dietary compounds - Trans-resveratrol (tRES) and hesperetin (HESP) - improves glucose metabolic profile and arterial function in overweight and obese subjects through inducing the gene expression of glyoxalase 1 (GLO1), an enzyme that detoxifies reactive metabolites during glycolysis and protects cells against glycation stress. Our pilot data indicated that tRES+HESP improved wound healing in diabetic animals with an increase in GLO1 expression. However, its effects are likely far beyond inducing GLO1 expression because tRES+HESP treated ECs produced many pro-angiogenic factors, including angiopoietin-1 (ANGPT1) that plays an essential role in angiogenesis. Therefore, it is critical to determine proteins that are regulated by tRES+HESP in angiogenesis and tissue repair. The objective of this project is to fill the knowledge gap of the role of tRES+HESP in rescuing the disrupted angiogenesis in diabetes, and our long-term goal is to develop therapeutic strategies for diabetic wound repair. We hypothesize that tRES+HESP augments angiogenesis and improves diabetic wound healing through enhancing the expression of GLO1 and a potent pro-angiogenic factor, ANGPT1, and through novel changes in additional proteins in pathways critical to diabetic wound repair. Aim 1: Identification of molecular pathways and protein changes induced by tRES+HESP in human dermal microvascular ECs in vitro. Sub-aim 1: Determine to what extent tRES+HESP can rescue diabetic endothelial cell function in vitro. Sub-aim 2: Determine how vital ANGPT1 is in tRES+HESP-induced angiogenesis in vitro. Sub-aim 3: Discover new proteins and pathways responsible for the benefit of tRES+HESP treatment in endothelial cell function in vitro using state- of-the-art proteomics. Aim 2: Determine the therapeutic potential of tRES+HESP and its underlying molecular mechanisms in chronic diabetic wounds in vivo. Sub-aim 1: Determine the efficacy of tRES+HESP on wound healing in a newly developed diabetic chronic wound model in db/db mice. Sub-aim 2: Determine the role of ANGPT1 in the tRES+HESP-induced improvement in wound healing in vivo. Sub-aim 3: Discover new proteins and pathways responsible for the benefit of tRES+HESP treatment in diabetic wound repair in vivo using state- of-the-art proteomics. The outcome of the proposed research will determine the efficacy of topical application of this formula, tRES+HESP, in diabetic wound healing, and will unveil underlying molecular mechanisms for its beneficial effect. Since tRES+HESP has not been approved by the FDA to treat diabetic wound healing yet, these results may facilitate the FDA approval of this coformulation in diabetic wound treatment.
糖尿病足溃疡导致截肢是一个主要的健康问题,在3000万糖尿病患者中约有20%受到影响 在美国的病人。目前的方案效果有限,截肢率仍然很高。因此, 了解具有翻译潜力的化合物的分子机制是制造 伤口护理方案的突破。内皮细胞(ECs)是人体不可缺少的细胞成分 伤口血管生成。然而,糖尿病患者的EC功能受损。两者的共同提法 膳食化合物-反式白藜芦醇(Tres)和橙皮素(Hesp)-改善葡萄糖代谢状况和 超重和肥胖者通过诱导乙二酸酶1(GLO1)基因表达来实现动脉功能 一种在糖酵解过程中解毒活性代谢物并保护细胞免受糖基化压力的酶。我们的 试验数据表明,TRES+HESP通过增加GLO1促进糖尿病动物的伤口愈合 表情。然而,它的作用可能远远不止诱导GLO1的表达,因为tres+hesp处理过 内皮细胞产生许多促血管生成因子,包括血管生成素-1(ANGPT1),它在 血管生成。因此,确定在血管生成过程中受tres+hesp调控的蛋白质是至关重要的。 和组织修复。这个项目的目标是填补关于tres+hesp在救援中的作用的知识空白。 糖尿病血管生成受阻,我们的长期目标是开发糖尿病的治疗策略 伤口修复。我们假设TRES+Hesp促进血管生成并促进糖尿病创面愈合 通过增强GLO1和一种强有力的促血管生成因子ANGPT1的表达,以及通过新的 糖尿病伤口修复的关键途径中额外蛋白质的变化。目标1:分子鉴定 Tres+Hesp体外诱导人真皮微血管内皮细胞的通路和蛋白质变化。子目标 1:确定TRES+HESP在多大程度上能在体外挽救糖尿病内皮细胞功能。次级目标2: 确定ANGPT1在TRES+Hesp诱导的体外血管生成中有多重要。次级目标3:发现新的蛋白质 以及TRES+HESP治疗对内皮细胞功能的影响的途径。 最先进的蛋白质组学。目的2:确定TRES+HESP及其潜在分子的治疗潜力 体内慢性糖尿病创面的机制。次级目标1:确定TRES+Hesp对伤口的疗效 Db/db小鼠新发展的糖尿病慢性创面模型的愈合。次级目标2:确定 TRES+HESP中的ANGPT1在体内可促进创面愈合。次级目标3:发现新的蛋白质 以及在体内糖尿病创面修复中TRES+Hesp治疗受益的途径。 最先进的蛋白质组学。拟议的研究结果将决定外用药物的疗效。 Tres+Hesp在糖尿病伤口愈合中的作用,并将揭示其潜在的分子机制 有益的效果。由于TRES+HESP尚未被FDA批准用于治疗糖尿病伤口愈合, 这些结果可能有助于FDA批准该联合制剂用于糖尿病伤口治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiemei Wang其他文献

Jiemei Wang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiemei Wang', 18)}}的其他基金

Mechanistic study of Small-molecular Therapy in diabetic Wound Healing
小分子治疗糖尿病伤口愈合的机制研究
  • 批准号:
    10569598
  • 财政年份:
    2021
  • 资助金额:
    $ 37.47万
  • 项目类别:
Role of Inositol requiring enzyme 1 in regulating angiogenesis for diabetic wound repair.
需要酶 1 的肌醇在调节糖尿病伤口修复血管生成中的作用。
  • 批准号:
    9222758
  • 财政年份:
    2016
  • 资助金额:
    $ 37.47万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 37.47万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了